Diseases (AASLD) also presented and continued to revise their clinical practice guidelines,
and the latest updates were in 2015, 2017, and 2018. However, since the medical …

Hepatitis B virus (HBV) infection remains a global public health problem with changing
epidemiology due to several factors including vaccination policies and migration. This …

Simple Summary This review reports the risk and management of the hepatotoxicity of all the
approved protein kinase inhibitors (PKIs) for cancer. Hepatotoxicity is one of the major safety …

Chronic hepatitis B (CHB) is a major cause of chronic liver diseases in Korea and remains a
threat to public health due to its high morbidity and disease-related mortality. Since the latest …

Autoimmune hemolytic anemia (AIHA) may be frequently challenged by infectious
complications, mainly as a result of immunosuppressive treatments administered …

Background Patients with multiple sclerosis (MS) often receive disease-modifying therapies
(DMTs) that can expose them to reactivation of potential occult hepatitis B virus (HBV) …

Primary Evans syndrome (ES) is defined by the concurrent or sequential occurrence of
immune thrombocytopenia and autoimmune hemolytic anemia in the absence of an …

Objective The objective of this study was to assess the possibility of HBV reactivation (HBVr)
in patients with RA under anti-IL-6 treatment. Methods Using PubMed, Scopus and …

Hepatitis B Virus (HBV) reactivation in patients receiving chemotherapy, biologicals,
immunosupressants, or corticosteroids is emerging to be an important cause of morbidity …

Chimeric antigen receptor‐T (CAR‐T) cell therapy is a promising treatment for CD19+ B‐cell
malignancies. However, elimination of B cells by anti‐CD19 CAR‐T cells may lead to the …